Concourse Financial Group Securities, Inc. Check Cap LTD Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	SELL	$0.06 - $7.2 $543 - $65,160	-9,050 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$1.15 - $3.07 $10,407 - $27,783	9,050 New	9,050 $16,000
Q4 2020 Feb 02, 2021	BUY	$0.26 - $0.46 $0 - $0	0 New	0 $0
Q3 2020 Nov 13, 2020	BUY	$0.32 - $0.8 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	BUY	$0.49 - $1.16 $0 - $0	0 New	0 $0
Q1 2020 May 13, 2020	BUY	$0.86 - $2.24 $0 - $0	0 New	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.31 - $1.98 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$1.87 - $2.26 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$2.12 - $2.77 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	BUY	$1.9 - $3.9 $0 - $0	0 New	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.04 - $4.17 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$3.21 - $4.16 $0 - $0	0 New	0 $0

Others Institutions Holding CHEK

# of Institutions

Shares Held

9.1K

Call Options Held

Put Options Held

American Portfolios Advisors Holbrook, NY

9.1K
Shares

$7,462
0.0% of portfolio

View Full List

About Check-Cap Ltd

Ticker CHEK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 116,412,000
Market Cap $95.5M
Description
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for d...

More about CHEK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account